Spotlight On... Pulmatrix taps Capsugel for R&D, manufacturing; Genomics firm raises $45M; and much more...

Capsugel and Pulmatrix ($PULM) have teamed up to develop new inhaled therapies for COPD, cystic fibrosis and idiopathic pulmonary fibrosis. News

> Cambridge, MA's Seven Bridges raised $45 million to support its large-scale genomics platform. More

> Drugmaker Athenex is planning to build a manufacturing plant in New York after securing a $225 million investment from the state. Item

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.